Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Monoclonal antibody resisting anaplasma marginale MSP5 protein and application thereof

A technology of monoclonal antibody and marginal anplasma disease, which is applied in the field of cell engineering and can solve problems such as limiting the application of monoclonal antibodies

Inactive Publication Date: 2012-11-07
HEILONGJIANG BAYI AGRICULTURAL UNIVERSITY +1
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, due to the fact that the domestic research on anplasma borderline has just been carried out, there is no report on its monoclonal antibody, which limits the application of monoclonal antibodies in the clinical diagnosis of anplasma borderline to a large extent. Therefore, The development of an ELISA diagnostic kit for detection of borderline aplasma disease is of great significance for the disease's epidemic monitoring, epidemiological investigation, and improvement of immunization strategies (Zhou Jie, Jiang Mo, Zhang Hongying, etc. Recombinant nucleocapsid of canine distemper virus Preparation and Identification of Protein Monoclonal Antibody [J], Chinese Journal of Preventive Veterinary Medicine, 2007, 29(7): 528-532)

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Monoclonal antibody resisting anaplasma marginale MSP5 protein and application thereof
  • Monoclonal antibody resisting anaplasma marginale MSP5 protein and application thereof
  • Monoclonal antibody resisting anaplasma marginale MSP5 protein and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0022] The preparation of embodiment 1 monoclonal antibody

[0023] 1. Purification and detection of recombinant protein

[0024] The induced protein rMSP5 was harvested after 5h, 6000rpm·min -1 Centrifuge for 10min, add 10mL of binding buffer. Resuspend the bacterial liquid, place the sample in an ice bath and ultrasonically lyse (30% power) lyse for 3 seconds with an interval of 15 seconds, and sonicate until the liquid becomes transparent. Then 11000rpm·min -1 Centrifuge for 20 minutes to remove cell debris, and transfer the supernatant to a new tube. Take the supernatant and precipitate separately for SDS-PAGE to determine whether the expressed protein is a soluble protein. Using the His-tag selective tag carried by the pQE30 vector, the protein was purified using Novagen’s instructions. The specific purification steps are as follows:

[0025] 1) Mix 3mL sterile deionized water with the resin, and suck out the supernatant after the resin sinks completely. Wash twice....

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a monoclonal antibody resisting anaplasma marginale MSP5 protein and an application thereof. The invention adopts the purified anaplasma marginale MSP5 protein expressed by escherichia coli as the immunogen to immune mice; a hybridoma cell line which can steadily secrete monoclonal antibody resisting anaplasma marginale MSP5 protein is obtained by cell fusion and screening; and the micromechanism collection number is CGMCC No.3205. The monoclonal antibody secreted by the hybridoma cell line can react with the anaplasma marginale MSP5, simultaneously can carry out idiosyncratic reaction with the cattle anaplasma marginale and the sheep anaplasma marginale, and can not react with mycoplasmas, neospora canimum, eperyt hrozoon and the like. The monoclonal antibody in the invention can be used for differentiating anaplasma marginale and other related pathogenies and provides material basis for the building of a rapid, convenient and accurate diagnostic method and for the immune mechanism research, immune function detection, detection method establishment and the like.

Description

technical field [0001] The invention relates to a monoclonal antibody, in particular to a monoclonal antibody against marginal aplasma MSP5 protein, and also relates to a hybridoma cell strain secreting the anti-MSP5 protein monoclonal antibody, which belongs to the field of cell engineering. Background technique [0002] Anaplasma disease, formerly known as anaplasmosis, is caused by Rickettsiales (Rickettsiales), Anaplasmataceae (Anaplasmataceae), Anaplasma marginale (Anaplasma marginale), central aplasma (A. centrale) and sheep aplasma (A.bovis) and other species parasitizing in red blood cells, mainly spread by blood-sucking arthropods (ticks, gadflies, stable flies, mosquitoes, etc.), and are transmitted by ticks. Parasitic Protozoa is the most widely distributed in the disease (Ristic M. Bovine anaplasmosis. Parasitic Protozoa, edited by Kreier J P, 1977, (IV): 235-249). Marginal and central anaplasts were first discovered in North Africa in 1910 and 1911. Since then...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N5/20C07K16/12G01N33/577A61K39/40A61P31/04
Inventor 倪宏波孙进华周玉龙王春仁姜海芳辛九庆宫大庆钱爱东
Owner HEILONGJIANG BAYI AGRICULTURAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products